[Cellular and immunologic reactivity during cytostatic therapy of solid tumors in childhood]. 1974

M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D009217 Myosarcoma A general term for a malignant neoplasm derived from muscular tissue. (Stedman, 25th ed) Myosarcomas
D002813 Chondrosarcoma A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed) Chondrosarcomas
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012208 Rhabdomyosarcoma A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9) Rhabdomyosarcomas

Related Publications

M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
February 1979, Anasthesiologische und intensivmedizinische Praxis,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
July 1985, Gematologiia i transfuziologiia,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
June 1980, Tumori,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
April 1982, MMW, Munchener medizinische Wochenschrift,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
February 1978, Ugeskrift for laeger,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
January 1971, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
January 1990, Acta medica Iugoslavica,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
December 1971, Langenbecks Archiv fur Chirurgie,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
March 2021, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting,
M Reitz, and J D Beck, and P Gutjahr, and H Schulte-Wissermann, and E M Lemmel
December 1978, Deutsche zahnarztliche Zeitschrift,
Copied contents to your clipboard!